Rethinking Cannabis Classification: Beyond Indica and Sativa

For decades, cannabis consumers have relied on the terms "indica" and "sativa" to guide their choices and predict the effects of different strains. Conventional wisdom has long held that indica strains produce relaxing, sedative effects, while sativa strains offer energizing, uplifting experiences. However, as cannabis research advances, experts are challenging this simplistic view, revealing a far more complex picture of how cannabis interacts with the human body and mind.

The Historical Origins of Indica and Sativa

The distinction between indica and sativa goes back to the late 1700s when French biologist Jean-Baptiste Lamarck first proposed categorizing cannabis plants based on their physical traits. Lamarck's classification was straightforward:

• Indica plants were typically shorter, with sturdy, woody stems and broad leaves.

• Sativa plants were taller, with fibrous stems and narrow leaves.

Lamarck's classification was rooted in the need to differentiate between cannabis varieties based on their utility and appearance. Indica plants were often associated with fiber production due to their tough, woody stems, making them ideal for crafting textiles and ropes. Sativa plants, on the other hand, were cultivated for their psychoactive properties, especially in regions where cannabis was used for spiritual or medicinal purposes. However, this early classification system was based purely on the physical characteristics of the plants and did not take into account their chemical composition or potential effects on human physiology.

As cannabis cultivation spread globally, the terms "indica" and "sativa" became more entrenched in popular culture. Farmers and botanists began to use these terms to describe not just the plants' physical traits, but also their purported effects. Over time, these classifications were simplified into the idea that indica strains were for relaxing, and sativa strains were for energy. But this oversimplification ignored the plant's complex chemistry and the influence of various growing conditions, which can significantly alter a strain's effects.

The Chemical Reality of Cannabis Effects

Dr. Ethan Russo, a neurologist and researcher in psychopharmacology, has been vocal in challenging the validity of the indica-sativa divide. In a 2016 interview with Cannabis and Cannabinoid Research, Russo bluntly stated, "The way that the sativa and indica labels are utilized in commerce is nonsense. The clinical effects of cannabis have nothing to do with whether the plant is tall and sparse or short and bushy, or whether the leaves are narrow or broad."

Russo’s critique is grounded in decades of research into the endocannabinoid system, which is the network of receptors in the human body that interacts with cannabinoids. This system is highly complex and varies greatly from person to person, meaning that the same strain of cannabis can have different effects on different individuals. The focus, therefore, should not be on the plant's appearance but on its chemical composition, which includes cannabinoids, terpenes, and other compounds that interact synergistically to produce a wide range of effects.

Echoing this sentiment, neuroscientist Nick Jikomes, who previously served as the director of science and innovation at Leafly, emphasizes that a plant’s chemical composition—not its physical structure—dictates how it will interact with the body and mind. "You can't just look at a plant and predict how it will affect your body and mind," Jikomes explains, highlighting the complexity of cannabis effects. He points out that even within the same strain, the chemical profile can vary from batch to batch depending on how it was grown, harvested, and processed.

Furthermore, Jikomes argues that the focus on indica and sativa labels has led to a misunderstanding of what actually drives the effects of cannabis. It's not just about whether a strain is indica or sativa, but about its specific cannabinoid and terpene profile. This profile can tell us much more about how a strain will affect the user than the simple classification as indica or sativa.

Debunking the Indica vs. Sativa Myth

The widespread belief that indica strains will invariably knock you out while sativas will rev you up simply doesn’t hold up under scientific scrutiny. Alex Pasternack, co-founder and president of the international cannabis brand Binske, offers a vivid analogy: "People think that if you smoke an indica, it's like taking a Xanax and you're going to be falling asleep, whereas a sativa is almost like doing a line of cocaine and you're going to be jacked up and hyper."

However, recent studies paint a different picture:

• In a 2021 study published in PLOS ONE, Jikomes and his team analyzed the chemical profiles of over 90,000 commercial cannabis samples across six U.S. states. They found no consistent chemical differences between strains labeled as indica or sativa. The study revealed that the chemical makeup of these strains was much more diverse and overlapping than the simple indica-sativa dichotomy would suggest. In many cases, strains labeled as indica contained chemical profiles similar to those labeled as sativa, and vice versa.

• Another study from Dalhousie University, also published in 2021 in the Journal of Cannabis Research, examined nearly 300 cannabis strains. The researchers found no scientific basis for the indica-sativa distinction when it comes to chemical composition. They concluded that the differences in effects attributed to these categories were more likely due to individual cannabinoids and terpenes rather than the indica or sativa classification.

• A 2015 study in PLOS ONE by Sawler et al. revealed that the genetic structure of marijuana and hemp samples did not align with the commonly accepted indica-sativa subspecies distinction. This study showed that the genetic differences between so-called indica and sativa strains were minimal and not significant enough to support the idea that these two categories represent distinct subspecies of cannabis.

These findings underscore the need to move beyond the simplistic labels of indica and sativa and toward a more nuanced understanding of cannabis. The effects of cannabis are determined by a complex interplay of cannabinoids, terpenes, and other chemical compounds, which can vary widely even within the same strain. By focusing on these chemical profiles rather than outdated classifications, consumers can make more informed choices about the strains that will best meet their needs.

The Complex Chemistry of Cannabis

Cannabis is a chemical powerhouse, with a myriad of compounds contributing to its effects:

• Cannabinoids: With over 140 identified cannabinoids, THC (tetrahydrocannabinol) and CBD (cannabidiol) are the most well-known, but others like CBG (cannabigerol) and CBN (cannabinol) are increasingly recognized for their potential therapeutic benefits. THC is the primary psychoactive compound in cannabis, responsible for the "high" that users experience, while CBD is non-psychoactive and is known for its potential therapeutic properties, such as reducing anxiety and inflammation.

• Terpenes: These aromatic compounds not only give cannabis its signature smell but also play a significant role in its effects. For instance:

  • Myrcene is often associated with sedative effects and may enhance THC’s psychoactive properties. It's commonly found in strains that are labeled as indica and is thought to contribute to the "couch-lock" effect that some users experience.

  • Limonene is linked to mood elevation and stress relief. This terpene is often found in strains that are labeled as sativa and is thought to contribute to their uplifting effects.

  • Pinene might help counteract some of THC's memory-impairing effects. It's one of the most common terpenes in nature and is found in many cannabis strains.

• Flavonoids: These compounds contribute to the plant’s color and have potential anti-inflammatory and antioxidant properties. Flavonoids are less studied than cannabinoids and terpenes, but they are believed to play a role in the overall effects of cannabis, particularly in their interaction with other compounds in the plant.

The "entourage effect," a term popularized by Dr. Russo, describes how these compounds work together to create the overall effects of a cannabis strain. Rather than focusing on just THC or CBD, the entourage effect suggests that all of the plant's compounds, including minor cannabinoids, terpenes, and flavonoids, interact synergistically to produce a more comprehensive range of effects. This concept is critical in understanding why the effects of cannabis cannot be easily categorized by simple labels like indica or sativa.

Moving Towards a New Classification System

As the cannabis industry evolves, there's a growing call for a more scientifically grounded classification system. Pasternack suggests a labeling approach similar to nutrition facts on food packaging, listing key compounds and their respective amounts. Such a system would provide consumers with detailed information about the cannabinoid and terpene content of each strain, allowing them to make more informed decisions based on the specific effects they are seeking.

Dr. Russo advocates for a chemotype system, focusing on the chemical composition of cannabis varieties. This approach would categorize cannabis based on its cannabinoid and terpene profiles, offering a more accurate prediction of effects. Chemotyping involves analyzing the chemical makeup of a cannabis strain and categorizing it based on the dominant cannabinoids and terpenes. This system could lead to a more precise and personalized approach to cannabis consumption, where consumers choose strains based on the specific chemical compounds that match their desired effects.

Some companies are already heading in this direction. For example, Bedrocan, a Dutch medical cannabis company, uses standardized chemovars (chemical varieties) to ensure consistent chemical profiles across batches. By standardizing the chemical profiles of their products, Bedrocan can offer patients a more predictable and reliable experience, which is especially important for medical cannabis users who rely on consistent effects for managing symptoms.

Other companies are experimenting with labeling systems that highlight the dominant terpenes in a strain, providing consumers with a clearer understanding of what to expect. For instance, some dispensaries group strains based on their dominant terpene profiles rather than using the traditional indica-sativa classification. This approach allows consumers to select strains based on the specific effects they are seeking, such as relaxation, focus, or creativity, rather than relying on outdated and oversimplified labels.

The Future of Cannabis Classification

While the simplicity of the indica-sativa system still appeals to many consumers and retailers, the ongoing shift towards more accurate classifications seems inevitable. As Jikomes puts it, "The whole system is just whether you want an upper or a downer. It enables retailers and brands to have a universal, foolproof way to market an arbitrary set of products to any consumer, and it's simple enough that anyone can understand it."

However, as the cannabis industry continues to grow and evolve, there is increasing recognition that consumers are becoming more sophisticated in their understanding of cannabis. With the rise of cannabis education and the availability of more detailed information about strains, consumers are beginning to demand more accurate and meaningful labels that reflect the true nature of the plant.

The future of cannabis classification lies in a more nuanced understanding of its chemical composition and how these compounds interact with the human endocannabinoid system. As research progresses, the industry may move towards a system that categorizes cannabis based on its chemotype, terpene profile, and other factors that influence its effects. This could lead to a more personalized and effective approach to cannabis use, where consumers can choose strains that are tailored to their specific needs and preferences.

In the meantime, some dispensaries are already adopting terpene-based classification systems, grouping strains by their dominant terpenes rather than the traditional indica-sativa categories. This shift represents a step towards a more accurate and science-based understanding of cannabis, where the focus is on the plant's chemical composition rather than outdated labels.

Final Thoughts

The science of cannabis is advancing rapidly, challenging long-standing beliefs about how we categorize and understand this complex plant. While the indica-sativa distinction may linger in popular culture for a while, the future of cannabis classification lies in a more nuanced understanding of its chemical composition and how these compounds interact with the human endocannabinoid system. As research progresses, consumers can look forward to more accurate, personalized recommendations that go beyond outdated and oversimplified categories.

In the coming years, the cannabis industry is likely to see a shift towards more sophisticated and scientifically grounded classification systems. As consumers become more educated about the complexities of cannabis, they will demand more accurate and meaningful labels that reflect the true nature of the plant. This shift will not only benefit consumers but also contribute to a more informed and responsible cannabis industry, where products are labeled and marketed based on their actual effects and chemical composition rather than outdated and oversimplified categorizations.

Don't forget to check out out STORE for available seeds and clones